Live Breaking News & Updates on Endocrine therapy interruption

Stay updated with breaking news from Endocrine therapy interruption. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Graff on the Relation Between ctDNA Positivity and Disease Recurrence in HR+/HER2– Breast Cancer

Stephanie L. Graff, MD, discusses findings from a pilot study exploring the association between disease recurrence and circulating tumor DNA positivity in patients with hormone receptor–positive, HER2-negative, node-positive, high-risk, early breast cancer who have received adjuvant treatment of abemaciclib and endocrine therapy.

San-antonio , Texas , United-states , Stephaniel-graff , Breast-cancer-translational-research-disease-group , Warren-alpert-medical-school , Lifespan-cancer-institute , Brown-university-legorreta-cancer-center , Brown-university , Legorreta-cancer-center , Antonio-breast-cancer-symposium

Dr Graff on the Impact of Endocrine Therapy Interruption on Conception in Breast Cancer Survivors

Stephanie L. Graff, MD, discusses the advantages of interrupting endocrine therapy in premenopausal patients with endocrine-responsive breast cancer who are seeking to conceive, based on findings from the phase 3 POSITIVE trial.

Stephaniel-graff , Brown-university-legorreta-cancer-center , Breast-cancer-translational-research-disease-group , Warren-alpert-medical-school , Lifespan-cancer-institute , Brown-university , Legorreta-cancer-center , Onclive-tv , Breast-cancer , Endocrine-therapy-interruption , Pregnancy